Lv51
874 积分 2023-09-03 加入
KRAS mutation-driven O-GlcNAcylation of CLDN18.2 enhances the progression of pancreatic cancer and reduces the efficacy of CLDN18.2-targeted therapy
12天前
已完结
Trogocytosis-orchestrated CLDN18.2-“dressed” CD8 + T cells drive pancreatic cancer progression via glucose metabolic reprogramming-induced cytotoxicity debilitation and systematic immune senescence cascade
12天前
已完结
Transfer Learning Reveals Cancer-Associated Fibroblasts Are Associated with Epithelial–Mesenchymal Transition and Inflammation in Cancer Cells in Pancreatic Ductal Adenocarcinoma
12天前
已完结
PI3K Regulates Wild-type RAS Signaling to Confer Resistance to KRAS Inhibition
1个月前
已完结
A High-Content Screening Workflow for Pancreatic Cancer Therapy Development Using Patient-Derived Tumor Organoid Cohorts: An Adaptation to Enable In Organoid Synergistic Drug Discovery
2个月前
已完结
Metabolic reprogramming drives pancreatic β cell neogenesis from α cells
2个月前
已完结
Targeting 5-Hydroxytryptamine Receptor 1A in the Portal Vein to Decrease Portal Hypertension
2个月前
已完结
Long-term Expansion of Epithelial Organoids From Human Colon, Adenoma, Adenocarcinoma, and Barrett's Epithelium
2个月前
已完结
Organoid Models of Human and Mouse Ductal Pancreatic Cancer
3个月前
已完结
Genetic Drivers of Sensitivity or Resistance to RAS(ON) Multiselective Inhibitors in NRAS -Mutated Melanoma
3个月前
已完结